Chinese State-Owned Sinopharm Capital Leads New Round In Medical Devices Provider

Sophy Yang
April 1, 2019 — 11:47 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Addor Capital AND Science & Technology biotech China chinese currency Expansion finance healthcare investment medical devices medicine pharmaceutical Private Equity procurement Renminbi Sinopharm Capital sports Suzhou technology venture capital Website Yuan

Related News:

China Establishes Nationwide Regulations for Commercial Use of Autonomous Vehicles

December 6, 2023 — 01:50

China’s Energy Sector Invests in Hydrogen Projects to Achieve National Dual Carbon Goals

December 4, 2023 — 23:32

Chinese Charitable Foundations Expand Into Alternative Investments To Enhance Returns

November 30, 2023 — 23:50

ByteDance’s ChatGPT-Powered AI Chatbot Cici Tops Charts in Emerging Markets

November 29, 2023 — 23:23

ByteDance to Dissolve Gaming Unit After Failing to Find a Buyer

November 28, 2023 — 03:29

Huawei Spins Off Intelligent Automotive Solutions Unit To Secure Fresh Funding

November 27, 2023 — 23:45

ByteDance Establishes New AI Division To Accelerate Consumer Product Deployment

November 27, 2023 — 23:10

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

ByteDance to Sell Moonton Gaming Studio in Strategic Retreat From Gaming

November 23, 2023 — 00:00